Different types of effective fractions from Radix Isatidis revealed a multiple-target synergy effect against respiratory syncytial virus through RIG-I and MDA5 signaling pathways, a pilot study to testify the theory of superposition of traditional Chinese Medicine efficacy

被引:20
作者
Xu, Huiqin [1 ]
He, Liwei [1 ,2 ]
Chen, Jing [3 ]
Hou, Xianbang [2 ]
Fan, Fangtian [2 ]
Wu, Hongyan [2 ]
Zhu, Hepeng [2 ]
Guo, Yeqian [2 ]
机构
[1] Nanjing Univ Chinese Med, Sch Pharm, Dept Pharmacol, Nanjing 210023, Jiangsu, Peoples R China
[2] Nanjing Univ Chinese Med, Dept Pharmacol, Hanlin Coll, POB 225312,6 Xueyuan Rd, Taizhou 225312, Peoples R China
[3] Yangzhou Univ, Inst Translat Med, Med Coll, Yangzhou 225001, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
Radix isatidis; RIG-I; MDA5; respiratory syncytial virus; Synergy; Traditional Chinese medicine; JINXIN ORAL LIQUID; ANTIVIRAL ACTIVITIES; INFECTION; EXTRACT; DRUG;
D O I
10.1016/j.jep.2019.111901
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: Radix Isatidis, a commonly used traditional Chinese medicine, is also documented in "Dictionary of Chinese Ethnic Medicine" being as an ethnic herb clinically utilized by different nations in China such as Mongol, Uygur, and Dong et al. It has been reported to have a very strong efficacy on respiratory viruses, but to date the mechanism remains unknown. Similarly, it is unclear how different types of effective fractions of Radix Isatidis interact to exert antiviral effects. Aim of study: To reveal the underlying mechanisms for the inhibitory effects of three active fractions from Radix Isatidis, i.e. total alkaloids, lignans and organic acids, on respiratory syncytial virus when used alone or in combination. In addition, we investigated whether these three parts worked synergistically in vivo and in vitro. Materials and methods: A mouse model of RSV infection was constructed by intranasal infection, and the pathological changes of lung tissues in different parts were observed. The level changes of IFN beta and inflammatory cytokines in the mouse alveolar lavage fluid were detected by enzyme-linked immunosorbent assay (ELISA). The anti-RSV effects of different effective fractions were evaluated by the plaque reduction test. The mRNA and protein expressions of RIG-I, MDA-5, MAVS and IRF3 in RAW264.7 cells were detected by RT-PCR and Western blot respectively. Results: HE staining showed that Radix Isatidis extracts alone or in combination relieved virus-induced mouse lung lesions. Compared with individual drugs, the lung lesions were alleviated more significantly after treatment with the three fractions in combination. ELISA demonstrated that the expression levels of IFN beta and inflammatory cytokines were maintained balanced between antiviral and proinflammatory effects. The plaque reduction test indicated that the antiviral effect of combination treatment was much stronger than those of individual drugs. RT-qPCR and Western blot suggested that the mRNA and protein expression levels of key signaling molecules in the RIG-I and MDA5 pathways in mouse macrophages were down-regulated by different effective parts alone or in combination. Conclusions: The three effective fractions of Radix Isatidis have remarkable synergistic anti-RSV effects in vitro and in vivo, and total alkaloids and lignans show multi-target synergistic effects via the RIG-I and MDA5 signaling pathways.
引用
收藏
页数:9
相关论文
共 34 条
  • [1] Cai Shao-qing, 2015, Zhongguo Zhong Yao Za Zhi, V40, P3435
  • [2] Aerosolized ribavirin: the most expensive drug for pneumonia
    Chemaly, R. F.
    Aitken, S. L.
    Wolfe, C. R.
    Jain, R.
    Boeckh, M. J.
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2016, 18 (04) : 634 - 636
  • [3] Chen H., 2012, CHIN J ETMF, V9, P184
  • [4] Antiviral effects of Jinxin oral liquid against respiratory syncytial virus infection in the BALB/c mice model
    Chen, Zheng-Guang
    Luo, Hui
    Wang, Shou-Chuan
    Xu, Jian-Ya
    Li, Jia-Xi
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 2015, 162 : 287 - 295
  • [5] Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
    Chou, Ting-Chao
    [J]. CANCER RESEARCH, 2010, 70 (02) : 440 - 446
  • [6] IRF-1, RIG-I and MDA5 display potent antiviral activities against norovirus coordinately induced by different types of interferons
    Dang, Wen
    Xu, Lei
    Yin, Yuebang
    Chen, Sumui
    Wang, Wenshi
    Hakim, Mohamad S.
    Chang, Kyeong-Ok
    Peppelenbosch, Maikel P.
    Pan, Qiuwei
    [J]. ANTIVIRAL RESEARCH, 2018, 155 : 48 - 59
  • [7] Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge Study
    DeVincenzo, John P.
    McClure, Matthew W.
    Symons, Julian A.
    Fathi, Hosnieh
    Westland, Christopher
    Chanda, Sushmita
    Lambkin-Williams, Rob
    Smith, Patrick
    Zhang, Qingling
    Beigelman, Leo
    Blatt, Lawrence M.
    Fry, John
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (21) : 2048 - 2058
  • [8] Pharmacologic Advances in the Treatment and Prevention of Respiratory Syncytial Virus
    Empey, Kerry M.
    Peebles, R. Stokes, Jr.
    Kolls, Jay K.
    [J]. CLINICAL INFECTIOUS DISEASES, 2010, 50 (09) : 1258 - 1267
  • [9] Total Synthesis and Anti-Viral Activities of an Extract of Radix isatidis
    He, Li-Wei
    Liu, Hua-Qing
    Chen, Yu-Qing
    Yang, Jing-Yan
    Wang, Tian-Lin
    Li, Wei
    [J]. MOLECULES, 2014, 19 (12) : 20906 - 20912
  • [10] 4(3H)-Quinazolone regulates innate immune signaling upon respiratory syncytial virus infection by moderately inhibiting the RIG-1 pathway in RAW264.7 cell
    He, Liwei
    Fan, Fangtian
    Hou, Xianbang
    Wu, Hongyan
    Wang, Juan
    Xu, Huiqin
    Sun, Yun
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2017, 52 : 245 - 252